Lung ischemia-reperfusion injury: a molecular and clinical view on a complex pathophysiological process

Willem A. den Hengst, Jan F. Gielis, Judy Y. Lin, Paul E. Y. Van Schil, Leon J. De Windt, An L. Moens*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

237 Citations (Web of Science)

Abstract

den Hengst WA, Gielis JF, Lin JY, Van Schil PE, De Windt LJ, Moens AL. Lung ischemia-reperfusion injury: a molecular and clinical view on a complex pathophysiological process. Am J Physiol Heart Circ Physiol 299: H1283-H1299, 2010. First published September 10, 2010; doi:10.1152/ajpheart.00251.2010.-Lung ischemia-reperfusion injury remains one of the major complications after cardiac bypass surgery and lung transplantation. Due to its dual blood supply system and the availability of oxygen from alveolar ventilation, the pathogenetic mechanisms of ischemia-reperfusion injury in the lungs are more complicated than in other organs, where loss of blood flow automatically leads to hypoxia. In this review, an extensive overview is given of the molecular and cellular mechanisms that are involved in the pathogenesis of lung ischemia-reperfusion injury and the possible therapeutic strategies to reduce or prevent it. In addition, the roles of neutrophils, alveolar macrophages, cytokines, and chemokines, as well as the alterations in the cell-death related pathways, are described in detail.
Original languageEnglish
Pages (from-to)H1283-H1299
JournalAmerican Journal of Physiology-heart and Circulatory Physiology
Volume299
Issue number5
DOIs
Publication statusPublished - Nov 2010

Keywords

  • pulmonary
  • lung transplantation
  • ventilated ischemia

Cite this